Accelrys Releases New Modeling And Simulation Software For Life Science Researchers With Discovery Studio 2.5

San Diego, CA - Accelrys, Inc., a leading provider of scientific business intelligence software and services, announced the release of Discovery Studio 2.5, the most advanced computational chemistry and biology software environment for drug discovery available today. To meet the modern day challenges of drug discovery projects, this release features major new scientific developments, and a focus on enhancing user experience by providing significant usability enhancements, with a fully customizable interface and improved integration with Pipeline Pilot. Because it is built upon Pipeline Pilot, Accelrys' scientific operating platform, Discovery Studio 2.5 is an extensible virtual discovery environment that lets researchers integrate any tool they need to create solutions that are uniquely tailored to fit their research process.

"The new version of Discovery Studio is robust and offers a wide range of functionality," said Manel Lopez, Ph.D., senior scientist at Almirall, a leading pharmaceutical company headquartered in Barcelona, Spain. "I really like the customizable Discovery Guides panel. The new transmembrane protein modeling capabilities of the software are impressive, and will contribute greatly to my research."

SOURCE: Accelrys, Inc.